SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-025419
Filing Date
2020-09-16
Accepted
2020-09-16 20:01:18
Documents
2
Period of Report
2020-09-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1615
2 EX-24 DOCUMENT attachment1.htm EX-24 5306
  Complete submission text file 0000899243-20-025419.txt   8261
Mailing Address 33 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 33 HAYDEN AVENUE LEXINGTON MA 02421 617 621 8097
Dicerna Pharmaceuticals Inc (Issuer) CIK: 0001399529 (see all company filings)

IRS No.: 205993609 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DICERNA PHARMACEUTICALS, INC. 33 HAYDEN AVENUE LEXINGTON MA 02421
Business Address
Zeng Ling (Reporting) CIK: 0001824252 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36281 | Film No.: 201179856